2026 Thomas M. Kündig: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	83	1427	1302	39	32	271	28969
Medicine	83	15491	14574	230	218	273	29021

Thomas M. Kündig publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas M. Kündig sits on this spectrum.

62 publications 807+

This scientist: 271 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas M. Kündig D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas M. Kündig sits on this spectrum.

40 D-Index 157+

This scientist: 83 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas M. Kündig is affiliated with the University of Zurich in Switzerland and conducts research primarily in the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their scientific output includes substantial work in the subfields of Immunology and Allergy, Immunology, Molecular Biology, Dermatology, and Infectious Diseases.

Their main research topics cover areas such as Allergic Rhinitis and Sensitization, Food Allergy and Anaphylaxis Research, Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Immunotherapy and Immune Responses, RNA Interference and Gene Delivery, and SARS-CoV-2 and COVID-19 Research.

Frequent coauthors collaborating with Thomas M. Kündig include:

Pål Johansen
Steve Pascolo
Mark Mellett
Martin F. Bachmann
Julia-Tatjana Maul

Their publications often appear in several recurring journals, including:

Allergy
Dermatology
Clinical & Experimental Allergy
Methods in Molecular Biology
Pharmaceutics

Notable recent papers authored or co-authored by Thomas M. Kündig include:

Inflammation in acute myocardial infarction: the good, the bad and the ugly (2023, European Heart Journal)
Protamine-Based Strategies for RNA Transfection (2021, Pharmaceutics)
Safety Profile of a Virus-Like Particle-Based Vaccine Targeting Self-Protein Interleukin-5 in Horses (2020, Vaccines)
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2 (2021, Allergy)
Photochemical Internalization: Light Paves Way for New Cancer Chemotherapies and Vaccines (2020, Cancers)

Best Publications

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.

Klaus Pfeffer;Toshifumi Matsuyama;Thomas M. Kündig;Andrew Wakeham

2105
Citations
Differential T cell costimulatory requirements in CD28-deficient mice

Arda Shahinian;Klaus Pfeffer;Kelvin P. Lee;Thomas M. Kündig

1664
Citations
Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta

Haruhiko Suzuki;Haruhiko Suzuki;Thomas M. Kündig;Caren Furlonger;Andrew Wakeham;Andrew Wakeham

1033
Citations
The influence of antigen organization on B cell responsiveness

Martin F. Bachmann;Urs Hoffmann Rohrer;Thomas M. Kündig;Kurt Bürki

880
Citations
Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function

Hans-Willi Mittrücker;Toshifumi Matsuyama;Alex Grossman;Thomas M. Kündig

852
Citations
Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4.

A. Rahemtulla;W. P. Fung-Leung;M. W. Schilham;T. M. Kündig

844
Citations
Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development

Toshifumi Matsuyama;Toshifumi Matsuyama;Tohru Kimura;Tohru Kimura;Tohru Kimura;Motoo Kitagawa;Klaus Pfeffer;Klaus Pfeffer

771
Citations
Stroma-Derived Interleukin-34 Controls the Development and Maintenance of Langerhans Cells and the Maintenance of Microglia

Melanie Greter;Iva Lelios;Pawel Pelczar;Guillaume Hoeffel

685
Citations
On immunological memory.

Rolf M. Zinkernagel;Martin F. Bachmann;Thomas M. Kündig;Stephan Oehen

662
Citations
CD8 is needed for development of cytotoxic T cells but not helper T cells.

Wai-Ping Fung-Leung;Marco W. Schilham;Amin Rahemtulla;Thomas M. Kündig

653
Citations
Normal B lymphocyte development but impaired T cell maturation in CD45-Exon6 protein tyrosine phosphatase-deficient mice

Kenji Kishihara;Kenji Kishihara;Josef Penninger;Josef Penninger;Valerie A. Wallace;Valerie A. Wallace;Thomas M. Kündig

616
Citations
Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity.

Rolf M. Zinkernagel;Stephan Ehl;Peter Aichele;Stephan Oehen

611
Citations
Immune responses in interleukin-2-deficient mice

Thomas M. Kündig;Hubert Schorle;Martin F. Bachmann;Hans Hengartner

603
Citations
CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity

Rudolf Schmits;Jorge Filmus;Nicole Gerwin;Giorgio Senaldi

476
Citations
Duration of TCR stimulation determines costimulatory requirement of T cells.

Thomas M Kündig;Arda Shahinian;Kazuhiro Kawai;Hans-Willi Mittrücker

460
Citations
Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial.

Gabriela Senti;Bettina M. Prinz Vavricka;Iris Erdmann;Mella I. Diaz

421
Citations
Immunity in response to particulate antigen-delivery systems.

Tazio Storni;Thomas M Kündig;Gabriela Senti;Pål Johansen

410
Citations
Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice

Ryuichi Amakawa;Ryuichi Amakawa;Anne Hakem;Anne Hakem;Thomas M Kundig;Toshifumi Matsuyama;Toshifumi Matsuyama

394
Citations
A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses.

Andrea Jegerlehner;Alain Tissot;Franziska Lechner;Peter Sebbel

388
Citations
Fibroblasts as Efficient Antigen-Presenting Cells in Lymphoid Organs

Thomas M. Kündig;Thomas M. Kündig;Martin F. Bachmann;Claudio DiPaolo;John J. L. Simard

349
Citations

Frequent Co-Authors

Martin F. Bachmann University of Bern

Pamela S. Ohashi Princess Margaret Cancer Centre

Hans Hengartner University of Zurich

Tak W. Mak Princess Margaret Cancer Centre

Rolf M. Zinkernagel University of Zurich

Brunello Wüthrich University of Zurich

Adrian Bot MannKind Corporation (United States)

Andrew Wakeham Princess Margaret Cancer Centre

Tak W. Mak Princess Margaret Cancer Centre

Ludger Klimek Ghent University

External Links

Personal website of Thomas M. Kündig

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in combining immunology studies with healthcare careers, exploring nursing pathways offers valuable options. Programs like the fastest and easiest LPN programs provide a practical entry point into patient care, often available online and designed for swift completion.

Advancing to a Nurse Practitioner (NP) role adds greater responsibility and specialization. Students can research what is the easiest NP program to find flexible options that balance clinical training with theoretical knowledge, allowing a smoother path toward certification.

Specifically, those interested in mental health can benefit from top-tier training through the best online psychiatric mental health nurse practitioner programs. These programs emphasize clinical placements that are critical for hands-on experience within psychiatric immunology and related fields.

Cost is often a determining factor, so exploring the affordable PMHNP programs can help students find budget-friendly paths to rewarding careers in mental health nursing while leveraging their immunology background.